logo
Foundation

INTERNATIONAL ADVISORY COMMITTEE ON CLINICAL TRIALS IN MULTIPLE SCLEROSIS

The International Advisory Committee on Clinical Trials in Multiple Sclerosis is jointly supported by the US National Multiple Sclerosis Society (NMSS) and the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS). Click here for the Committee Charter. The Committee works to provide perspective and guidance in areas of interest to planning and implementation of clinical trials for new agents for the treatment of multiple sclerosis. The Committee works as a whole, in international meetings and consensus-building activities, or through subcommittees and task forces on specific topics. Historically, some of the Committee’s projects and publications of their outcomes have included:

In 2016-2017, the Committee will explore new diagnostic criteria for MS and spinal cord manifestations in MS.

ectrims_131-300x199 [fMRI during simple motor task; healthy volunteer (top) and PP MS subject (bottom) Photo M. Filippi, Ospedale San Raffaele, Milan
ectrims_111-300x199 Pathology of SPMS Photo H. Lassmann, University of Vienna
ectrims_181-300x199 MS t-cells Photo H. Lassmann, University of Vienna
ectrims_171-300x199 Arcuate fasciculus impacted by MS lesion Photo M. Filippi, Ospedale San Rafaelle, Milan
ectrims_10-1-300x199 Photo Congrex
bild optic disc palor after acute ON. Courtesy A. Toosy, London